Campbell Soup says it may outpace Wall Street profit estimate for 2024
By Steve Gelsi
Campbell Soup's stock rises but has lost about 24.6% of its value in 2023
Campbell Soup Co.'s stock rose Wednesday after the company said it may outpace analyst estimates for 2024 earnings per share.
Campbell Soup's stock (CPB) was up by about 6.4%, its first gain of that amount since December 2022, according to Dow Jones Market Data.
The food company said its first-quarter net income for the three months ending Oct. 29 fell to $407 million, or 78 cents a share, from $436 million, or 99 cents a share, in the year-ago quarter.
Adjusted first-quarter earnings of 91 cents a share beat the FactSet consensus estimate of 87 cents a share.
Revenue fell 2% to $2.52 billion, in line with the analyst estimate.
Looking ahead, Campbell Soup expects adjusted 2024 earnings of $3.09 to $3.15 a share, ahead of the FactSet consensus estimate of $3.07 a share.
Chief Executive Mark Clouse said the company's first-quarter results were in line with expectations.
"We are off to an encouraging start in our important holiday season," Clouse said.
Campbell Soup expects to close its acquisition of Sovos Brands in 2024.
While Campbell Soup's stock is up four of the past five days, the stock has lost about 24.6% of its value in 2023 and is on pace for its worst year since it fell 31.4% in 2018.
The stock remains 36.7% off its all-time high of $67.55 on July 6, 2016.
-Steve Gelsi
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
12-06-23 1058ET
Copyright (c) 2023 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks